Showing results (101-110 of 990) with videos related to

Sort By:
Pageof 99
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 23, 2018
Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance)Amanda I Phipps, Qian Shi, Tyler J Zemla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Racial differences in advanced colorectal cancer outcomes and pharmacogenetics: a subgroup analysis of a large randomized clinical trialHanna K Sanoff, Daniel J Sargent, Erin M Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Revised TN categorization for colon cancer based on national survival outcomes dataLeonard L Gunderson, John Milburn Jessup, Daniel J Sargent, et al.
Planta|February 8, 2025
Developmental processes in the Rosaceae through the lens of DNA and RNA methylationTamunonengiye-Ofori Lawson, Juan-Pablo Selva, José Carballo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Evaluation of alternate categorical tumor metrics and cut points for response categorization using the RECIST 1.1 data warehouseSumithra J Mandrekar, Ming-Wen An, Jeffrey Meyers, et al.
Statistics in Medicine|March 31, 2016
New insights into the evaluation of randomized controlled trials for rare diseases over a long-term research horizon: a simulation studyMohamed Amine Bayar, Gwénaël Le Teuff, Stefan Michiels, et al.
International Journal of Cancer|April 11, 2016
Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147Amanda I Phipps, Qian Shi, Paul J Limburg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
Comparison of error rates in single-arm versus randomized phase II cancer clinical trialsHui Tang, Nathan R Foster, Axel Grothey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling MethodsMing-Wen An, Yu Han, Jeffrey P Meyers, et al.
Pageof 99